###begin article-title 0
###xml 100 124 100 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli gltBDF </italic>
###xml 100 116 <span type="species:ncbi:562">Escherichia coli</span>
Integration of regulatory signals through involvement of multiple global regulators: control of the Escherichia coli gltBDF operon by Lrp, IHF, Crp, and ArgR
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF</italic>
###xml 110 126 110 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 216 224 216 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 294 301 294 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 640 646 640 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF</italic>
###xml 752 760 752 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 764 773 764 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 110 126 <span type="species:ncbi:562">Escherichia coli</span>
###xml 216 223 <span type="species:ncbi:562">E. coli</span>
The glutamate synthase operon (gltBDF) contributes to one of the two main pathways of ammonia assimilation in Escherichia coli. Of the seven most-global regulators, together affecting expression of about half of all E. coli genes, two were previously shown to exert direct, positive control on gltBDF transcription: Lrp and IHF. The involvement of Lrp is unusual in two respects: first, it is insensitive to the usual coregulator leucine, and second, Lrp binds more than 150 bp upstream of the transcription starting point. There was indirect evidence for involvement of a third global regulator, Crp. Given the physiological importance of gltBDF, and the potential opportunity to learn about integration of global regulatory signals, a combination of in vivo and in vitro approaches was used to investigate the involvement of additional regulatory proteins, and to determine their relative binding positions and potential interactions with one another and with RNA polymerase (RNAP).
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 300 307 300 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
Crp and a more local regulator, ArgR, directly control gltBDF transcription, both acting negatively. Crp-cAMP binds a sequence centered at -65.5 relative to the transcript start. Mutation of conserved nucleotides in the Crp binding site abolishes the Crp-dependent repression. ArgR also binds to the gltBDF promoter region, upstream of the Lrp binding sites, and decreases transcription. RNAP only yields a defined DNAse I footprint under two tested conditions: in the presence of both Lrp and IHF, or in the presence of Crp-cAMP. The DNAse I footprint of RNAP in the presence of Lrp and IHF is altered by ArgR.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 257 264 257 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 34 41 <span type="species:ncbi:562">E. coli</span>
The involvement of nearly half of E. coli's most-global regulatory proteins in the control of gltBDF transcription is striking, but seems consistent with the central metabolic role of this operon. Determining the mechanisms of activation and repression for gltBDF was beyond the scope of this study. However the results are consistent with a model in which IHF bends the DNA to allow stabilizing contacts between Lrp and RNAP, ArgR interferes with such contacts, and Crp introduces an interfering bend in the DNA and/or stabilizes RNAP in a poised but inactive state.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 121 137 <span type="species:ncbi:562">Escherichia coli</span>
###xml 337 344 <span type="species:ncbi:562">E. coli</span>
A small number of global regulatory proteins appear to play a central role in integrating the regulatory architecture of Escherichia coli, so as to promote coherent transcriptional responses to environmental changes. Just seven proteins (ArcA, Crp, FIS, Fnr, IHF, Lrp, and NarL) directly control expression of about half of all genes in E. coli [1]. We report here direct evidence that three of these seven proteins, plus a more specific regulator, cooperate to control an operon critical to nitrogen metabolism.
###end p 9
###begin p 10
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 310 311 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 71 87 <span type="species:ncbi:562">Escherichia coli</span>
There are two main pathways for assimilating ammonia into glutamate in Escherichia coli [2] (see Fig. 1). In the presence of high ammonia concentrations and limited carbon/energy, glutamate dehydrogenase (GdhA) produces glutamate from ammonia, alpha-ketoglutarate, and NADPH [equation 1, and left side of Fig. 1].
###end p 10
###begin p 11
###xml 2 3 2 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 55 57 49 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
NH4+ + alpha-Ketoglutarate + NADPH --> Glutamate + NADP+     [1]
###end p 11
###begin p 12
###xml 447 448 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 490 491 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 498 499 494 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
At low ammonia concentrations, a two-enzyme cycle is used instead. First, glutamine synthetase (GlnA) produces glutamine from ammonia, glutamate and ATP [equation 2]. Then glutamate synthase (GltBD) produces two molecules of glutamate from glutamine, alpha-ketoglutarate, and NADPH [equation 3], with one of the glutamate molecules going back into the cycle and the other representing net ammonia incorporation [equation 4, and right side of Fig. 1]. The only difference between equations [1] and [4] is the involvement of ATP.
###end p 12
###begin p 13
###xml 2 3 2 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 46 48 44 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
NH4+ + Glutamate + ATP --> Glutamine + ADP + Pi     [2]
###end p 13
###begin p 14
###xml 62 64 56 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Glutamine + alpha-Ketoglutarate + NADPH --> 2 Glutamate + NADP+     [3]
###end p 14
###begin p 15
###xml 2 3 2 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 61 63 55 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 72 73 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
NH4+ + alpha-Ketoglutarate + NADPH + ATP --> Glutamate + NADP+ + ADP + Pi   [4]
###end p 15
###begin p 16
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
In the presence of high ammonia levels, GltBD activity would waste ATP as a result of unnecessary glutamine turnover. The pathway represented by equation 4 is estimated to account for a remarkable 15% of total ATP turnover during growth in glucose minimal medium [2], so the ATP wastage would be substantial. However, insufficient GltBD activity in the face of dropping ammonia levels would lead to cessation of growth [3,4] and a competitive disadvantage. Clearly the level of GltBD must be very carefully controlled so as to anticipate the probable near-term needs of the cell.
###end p 16
###begin p 17
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 577 578 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 672 673 672 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 312 319 <span type="species:ncbi:562">E. coli</span>
Our interest in gltBDF, the operon that includes structural genes for GltBD, stems from its membership in the regulon controlled by Lrp (leucine-responsive regulatory protein) [5]. There is no obvious single role for Lrp, but three broad themes stand out. First, Lrp appears to sense the shift between two major E. coli environments, "the gut and the gutter" [6], activating many amino acid biosynthetic operons (such as gltBDF) and repressing many catabolic ones. Second, and partially overlapping the first, Lrp plays an important role in regulating nitrogen metabolism [2,5,7]. Third, Lrp appears to play an important role in preparing the cell for stationary phase [6,8-13].
###end p 17
###begin p 18
###xml 7 14 7 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 479 486 479 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 576 583 576 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 631 638 631 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 795 802 795 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
In the gltBDF operon, IHF binds the region from -75 to -113, while the three Lrp binding sites are centered at nucleotides -152, -215 and -246 relative to the transcription start site [5,14] (Fig. 2A). This arrangement leaves space for other proteins to bind, and it seemed likely that additional regulators would be involved in controlling a pathway that can account for 15% of the cell's ATP flux. There is some evidence for effects (direct or indirect) of other regulators on gltBDF expression, including Crp [15], Fnr [16], Nac [17], and GadE [18] (see information on the gltBDF operon at EcoCyc.org [19]). We report here that gltBDF is directly and negatively controlled by Crp and ArgR, in addition to the direct positive control by Lrp and IHF. We also show that RNAP binds stably to the gltBDF promoter in the presence of Lrp and IHF, or in the presence of Crp-cAMP.
###end p 18
###begin title 19
Results
###end title 19
###begin title 20
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
Effects of Lrp and IHF on RNAP binding to the gltBDF promoter region
###end title 20
###begin p 21
###xml 65 72 65 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB</italic>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
We have previously shown that Lrp and IHF bind simultaneously to gltBDF promoter (PgltB) DNA, yielding a band with intermediate gel shift mobility between the IHF-DNA and Lrp-DNA complexes (Fig. 3C in [14]). Fig. 3A shows that the Lrp-binding region yields a subtly altered Lrp-dependent DNAse I footprint in the presence of IHF, though the IHF footprint is not obviously changed by the presence of Lrp.
###end p 21
###begin p 22
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 422 429 422 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 521 525 521 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB</italic>
###xml 1005 1007 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1355 1357 1355 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1471 1473 1471 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
RNA polymerase holoenzyme (RNAP) binds to PgltB in the absence of other proteins, as revealed by electrophoretic mobility shift of a DNA segment from -406 to +131 (relative to the transcription start; not shown). However DNAse I footprinting analysis of this binary complex revealed no obvious regions of protection (Fig. 3B, compare lanes 5 and 6). Since the absence of either Lrp or IHF leads to a >30-fold reduction in gltBDF transcription [5,14], we investigated whether these two proteins influence RNAP binding to PgltB. Mobility shift experiments were not informative as, under our conditions, the large shift due to RNAP alone was indistinguishable from shifts due to RNAP together with Lrp and/or IHF. However DNAse I protection analysis revealed that the combination of Lrp, IHF and RNAP results in a footprint in the promoter region, with strongly enhanced cleavage at the -19 position of the template strand and protection in the remainder of the region between the -10 and -35 hexamers (Fig. 3B, compare lane 7 to lanes 5 and 6). This protection extended ~30 bp upstream of the -35 hexamer, merging with the footprint of IHF, and some protection was visible even farther upstream between the IHF and Lrp binding sites. A combination of just Lrp and IHF does not result in any additional footprint aside from those of the individual proteins [14], and in particular the extended protection upstream of the -35 hexamer is not seen in the absence of RNAP (Fig. 3A).
###end p 22
###begin title 23
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
Crp-cAMP regulation of gltBDF transcription
###end title 23
###begin p 24
###xml 33 41 33 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 239 246 230 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 288 290 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 532 539 523 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 545 546 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 578 583 569 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 655 657 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 752 755 743 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cya</italic>
###xml 885 887 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 989 993 980 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB</italic>
###xml 33 40 <span type="species:ncbi:562">E. coli</span>
We searched for proteins from an E. coli whole-cell extract that bound to immobilized, biotinylated PgltB DNA, using Ciphergen ProteinChipstrade mark and mass spectrometry. This method had previously implicated IHF as a factor involved in gltBDF regulation, as we subsequently confirmed [14], but additional mass peaks representing other DNA binding proteins had not yet been investigated. The analysis suggested ArgR (regulator for the arginine regulon) and Crp (catabolite repressor protein) as potential additional regulators of gltBDF (Fig. 4). Several decades ago Prusiner et al. reported negative regulation of glutamate synthase expression by Crp [15]. Specifically, glutamate synthase activity is doubled in a mutant lacking adenylate cyclase (cya), and reduced 1.5-fold by addition of exogenous cAMP or growth with glycerol as the carbon source (which increases cAMP levels) [15]. However, it was not determined whether these results involved direct interactions between Crp and PgltB.
###end p 24
###begin p 25
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 178 188 178 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB-lacZ </italic>
###xml 207 211 207 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp </italic>
###xml 215 218 215 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp</italic>
###xml 218 220 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 305 309 305 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp </italic>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 543 547 543 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glt </italic>
Our inspection of the gltBDF DNA sequence revealed a potential Crp-binding site between -76 and -55 (Fig. 5A, top two lines). We have not attempted to measure transcription of a gltB-lacZ fusion in isogenic crp and crp+ strains, to complement the earlier data of Prusiner et al. [15]. This is because the crp mutant grows much more slowly than its isogenic partner [20], and comparisons would be complicated by the different growth rates [21]. However we have taken three complementary approaches to demonstrate a direct effect of Crp-cAMP on glt transcription.
###end p 25
###begin p 26
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glt </italic>
###xml 170 172 170 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d </sub>
###xml 218 220 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 288 290 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 337 339 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
First, we carried out mobility shift assays using purified Crp and a gltBDF DNA fragment containing the region from -406 to +246. Crp bound the glt DNA with an apparent Kd of 35 nM in the presence of 20 muM cAMP (Fig. 5B). Replacing the region between -121 and -48 with heterologous DNA [14] resulted in loss of detectable binding (Fig. 5C). When cAMP was not added to the gel, but was present in the binding reaction, binding was still observed but the shifted bands were smeared, suggesting that the complexes were unstable under this condition (not shown).
###end p 26
###begin p 27
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 288 292 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB</italic>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
Second, we carried out DNAse I footprint analyses, using purified Crp, cAMP, and PgltB DNA. A defined region of partial protection was seen between -71 and -52 on the non-template strand (Fig. 5E), and -72 to -57 on the template strand (not shown). Thus Crp-cAMP interacts directly with PgltB. The Crp binding is centered at -65.5, in the predicted binding sequence (-76 to -55), and between the -35 hexamer and the IHF binding site (Fig. 2A).
###end p 27
###begin p 28
###xml 102 112 102 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB-lacZ </italic>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 364 371 364 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 600 604 598 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac </italic>
###xml 695 697 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 752 757 750 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
###xml 832 834 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 855 857 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 906 911 904 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
###xml 924 928 922 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB</italic>
###xml 941 943 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 987 992 985 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
###xml 1002 1007 1000 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
Third, we determined the effects of the membrane-permeable derivative dibutyryl-cAMP on expression of gltB-lacZ with and without alteration of the Crp binding sequence. The alterations are shown in Fig. 5A (bottom line), and replace all of the most highly-conserved nucleotides of known Crp-binding sequences (shaded) that were not already different in the native gltBDF promoter. Concentrations of dibutyryl-cAMP as high as 50 muM had no effect on the growth rate of the cultures (not shown), and we used 10 muM in the experiments described here. As a control, parental strain W3110 (with an intact lac operon) was grown in a defined glucose rich medium plus the inducer IPTG. As shown in Fig. 6A, dibutyryl-cAMP had the expected effect of increasing lacZ expression in the parental strain, due to relief of catabolite repression [22]. In contrast, Fig. 6B shows that dibutyryl-cAMP reduced expression of lacZ fused to WT PgltB, while Fig. 6C shows that dibutyryl-cAMP had no effect on lacZ fused to PgltB having the altered Crp binding sequence. Similar results were obtained in glucose minimal medium (not shown).
###end p 28
###begin p 29
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB</italic>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
As Crp most often acts as a transcription activator, we explored some possible explanations for its repressive effect on PgltB. One possibility, given the proximity of the Crp and IHF binding sites (Fig. 2A), and the requirement of IHF for activation by Lrp [14], is that Crp interferes with IHF binding. However mobility shift analysis indicates that Crp and IHF bind independently of one another (Fig. 5D), though the ternary and binary complexes could not be resolved from one another well enough to completely rule out limited negative (or positive) cooperativity in their binding.
###end p 29
###begin p 30
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 286 291 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 791 792 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
A second possibility, which we did not test, is that the Crp-induced bend in the DNA [23] opposes that generated by IHF, preventing proper activation. A third possibility is that Crp interferes with RNAP binding. As noted above, RNAP alone fails to yield a clear protection pattern on PgltB DNA. Adding Crp-cAMP, far from interfering with RNAP binding, resulted in the appearance of a well-defined pattern of RNAP-dependent protection (Fig. 7). This pattern is, however, distinct from that seen when the coactivators Lrp and IHF are added in place of Crp (Fig. 3B). One particularly striking difference, as an example, is the DNase cleavage at position -19, that shows hypersensitivity in the presence of Lrp + IHF but not in the presence of Crp (compare lane 7 of Fig. 3B to lane 7 of Fig. 7).
###end p 30
###begin title 31
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
ArgR-Arg regulation of gltBDF transcription
###end title 31
###begin p 32
###xml 79 87 70 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 109 114 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 194 196 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 226 233 217 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 386 396 377 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB-lacZ </italic>
###xml 435 438 426 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rph</italic>
###xml 438 440 429 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 473 474 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 494 499 485 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">argR </italic>
###xml 653 658 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">argR </italic>
###xml 79 86 <span type="species:ncbi:562">E. coli</span>
The Ciphergen ProteinChiptrade mark analysis referred to above yielded another E. coli polypeptide bound to PgltB DNA, having a molecular mass close to that of the regulatory protein ArgR (Fig. 4A). The involvement of ArgR in gltBDF regulation is reinforced by the following three observations. First, adding 7.5 mM L-arginine to MOPS-glucose medium nearly halved LacZ activity, in the gltB-lacZ fusion strain LP1000 (and its isogenic rph+ strain LP2020; see below) (Table 1). Second, deleting argR from strains LP1000 (LP1050) or LP2020 (LP2023) doubled LacZ activity. Third, adding arginine to the growth medium did not affect LacZ levels in the DeltaargR strain LP1050.
###end p 32
###begin p 33
###xml 65 72 65 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 257 264 257 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 359 369 359 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB-lacZ </italic>
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 522 527 522 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 553 554 553 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 554 555 554 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 555 559 555 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">app </sup>
###xml 583 585 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 670 671 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 671 672 669 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 672 676 670 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">app </sup>
###xml 780 782 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 783 785 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
We have evidence that ArgR mediates its regulatory effect on the gltBDF promoter via direct interaction. There are two good matches to the consensus ArgR binding site sequence [24,25] upstream of the promoter-distal Lrp binding site (Figs. 2A and 8A). When gltBDF DNA containing the putative ArgR sites upstream of -270 was deleted, arginine had no effect on gltB-lacZ expression (strain LP1270, Table 1). We extended this observation by using purified ArgR in mobility shift and DNAse I footprint analyses. ArgR bound to gltB DNA (-406 to +246) with a Kdapp of 1.8 +/- 0.7 nM (Fig. 8B), and to a 3'-shortened fragment (-406 to -128) with essentially the same affinity (Kdapp of 1.7 +/- 0.06 nM; not shown). These data were fitted using the Hill equation as previously described [26-28], and both binding curves were characterized by a Hill coefficient of 2.0, indicating that multiple ArgR molecules are binding cooperatively.
###end p 33
###begin p 34
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
The sequence to which ArgR binds was determined by DNase I protection using gltB DNA from -462 to +161. ArgR protected a region upstream of the distal Lrp binding site (Figs. 2A and 8C), extending from -361 to -318 on the non-template strand. This encompasses the two ArgR consensus-matching sites, and is consistent with the Hill coefficient of 2.0. Similar results were obtained for the template strand (not shown; a longer fragment, extending from -575 to +131, gave lower resolution due to the position of the footprint on the fragment).
###end p 34
###begin p 35
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
We considered two possibilities for the basis of gltBDF repression by ArgR. First, given the proximity of the ArgR and Lrp binding sites (Fig. 2A), we tested whether ArgR interfered with Lrp binding. Mobility shift assays with ArgR and Lrp were inconclusive in this respect, because adding the corepressor arginine to the gel prevented the Lrp-DNA complex from migrating far into the gel (not shown). However DNAse I footprint analyses suggest that Lrp and ArgR bind independently of one another (Fig. 9A).
###end p 35
###begin p 36
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
A second possible basis for repression of gltBDF by ArgR involves interference with the proposed Lrp-RNAP interaction. ArgR does in fact alter the protection pattern generated by the combination of Lrp, IHF, and RNAP (Fig. 9B, asterisks). In the absence of ArgR there is a limited region of RNAP-dependent hypersensitivity that overlaps the ArgR binding site; addition of ArgR and arginine alters this hypersensitivity pattern.
###end p 36
###begin title 37
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
Effects of rph on gltBDF expression
###end title 37
###begin p 38
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 112 120 112 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 157 159 157 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K-</italic>
###xml 202 205 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rph</italic>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pyrE </italic>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 607 614 607 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 774 784 773 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB-lacZ </italic>
###xml 841 851 840 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB-lacZ </italic>
###xml 868 872 863 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac </italic>
###xml 907 911 902 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rph </italic>
###xml 1014 1018 1009 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rph </italic>
###xml 1062 1067 1057 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 1112 1116 1103 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac </italic>
###xml 1122 1132 1113 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB-lacZ </italic>
###xml 1150 1151 1141 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1254 1262 1245 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 112 119 <span type="species:ncbi:562">E. coli</span>
###xml 1254 1261 <span type="species:ncbi:562">E. coli</span>
We considered the possibility that our measurements of gltBDF expression were being affected by a defect in the E. coli W3110 background. This commonly-used K-12 strain carries a frameshift mutation in rph, the structural gene for RNAsePH, that results in decreased pyrE (orotate phosphoribosyltransferase) expression and in turn leads to pyrimidine limitation during growth in minimal media [29]. Pyrimidine biosynthesis is regulated by feedback inhibition, so it seemed plausible that W3110 would sense increased demand for glutamate (to provide needed glutamine precursors), and would thus have elevated gltBDF expression. Consistent with this possibility, adding 20 mug/ml of the pyrimidine uracil to strain LP1000 in minimal medium resulted in a 1.5 fold reduction of PgltB-lacZ activity (strain LP1000 is a W3110 derivative carrying a gltB-lacZ fusion in a Deltalac background). We replaced the W3110 rph allele with the wild-type gene (see Methods), and the new strain was designated LP2002. Correcting the rph mutation roughly halved transcription from PgltB in strain LP2020 (strain LP2002 bearing Deltalac and a gltB-lacZ fusion, see Table 2), in agreement with the uracil addition results. Strain LP2002 may be generally useful for studies of E. coli physiology.
###end p 38
###begin title 39
Discussion
###end title 39
###begin title 40
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBD </italic>
Role of IHF in mediating activation of gltBD by Lrp
###end title 40
###begin p 41
###xml 28 30 28 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 349 354 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ilvP </italic>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 577 582 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 818 828 818 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB-lacZ </italic>
###xml 953 955 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 965 970 965 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 973 975 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1084 1086 1084 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
IHF, a DNA-bending protein [30], is required for activation of gltBDF transcription by Lrp [14]. IHF subtly affects the Lrp-dependent DNAse I footprint (Fig. 3A), suggesting that IHF alters the Lrp-DNA complex (or alters DNAse I access to that complex). In addition, IHF bending could bring the Lrp-DNA complex into activating contact with RNAP at PgltB (Fig. 2B). IHF plays an architectural role at several activated promoters, such as PilvP [31]. We have not directly demonstrated looping, but two results support this view. First, no defined footprint for RNAP was seen at PgltB with either IHF or Lrp alone, only with both together (Fig. 3B and our unpublished results). Second, an earlier study demonstrated that a 5 bp (half helical turn) insertion between the proximal Lrp binding site and the promoter reduced gltB-lacZ expression 3-7-fold, while a 10 bp (full helical turn) insertion at the same location did not reduce fusion expression (Fig. 5B of Wiese et al. [26]). Bending or looping models do not rule out the possibility of direct RNAP-IHF contacts occurring as well [32].
###end p 41
###begin title 42
Does Crp pre-position RNAP in response to energy metabolism?
###end title 42
###begin p 43
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 293 300 293 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 334 339 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 435 443 435 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 491 498 491 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 795 800 795 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gdhA </italic>
###xml 804 808 804 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gdhA</italic>
###xml 808 810 808 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 819 820 819 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 821 822 821 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 857 861 857 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gdhA</italic>
###xml 861 863 861 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1088 1089 1088 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1090 1091 1090 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1228 1230 1228 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1321 1327 1321 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glnAp2</italic>
###xml 1330 1332 1330 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 293 300 <span type="species:ncbi:562">E. coli</span>
###xml 435 442 <span type="species:ncbi:562">E. coli</span>
The flux through the GlnA/GltBD pathway can be quite high in minimal media. ATP is required for the GlnA/GltBD pathway and not for the GdhA pathway (Fig. 1), and governing the relative fluxes through these alternative pathways is probably one of the most critical regulatory problems faced by E. coli. We report direct regulation of PgltB by Crp, in agreement with earlier indirect evidence [15]. A microarray-based global analysis of E. coli genes affected by Crp [33] did not identify the gltBDF operon, but this probably reflects the rich culture medium (LB) used in that work. Crp is broadly associated with the control of carbon and energy source utilization, usually activating genes for utilization of less-efficient carbon/energy sources (relative to glucose) [33]. Competitions between gdhA and gdhA+ strains [3,4] reveal a clear advantage for the gdhA+ strain during glucose limitation, suggesting that Crp modulates the relative activities of the two alternative pathways for glutamate synthesis to favor the ATP-independent pathway during growth on suboptimal carbon sources [3,4]. The reciprocal effects of carbon source and addition of cAMP on GdhA and GltBD activities are consistent with just this role for Crp [15]. In addition, Crp-cAMP represses one of the promoters for the glutamine synthetase gene (glnAp2) [34], so both enzymes for the GlnA/GltBD pathway are controlled in parallel by Crp.
###end p 43
###begin p 44
###xml 36 45 36 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 51 56 51 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B, E</xref>
###xml 99 107 99 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 637 639 629 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">70</sup>
###xml 784 789 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 817 819 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 844 849 836 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 971 973 963 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1005 1007 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1008 1010 1000 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1077 1080 1065 1068 <sup xmlns:xlink="http://www.w3.org/1999/xlink">70 </sup>
###xml 1162 1164 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1183 1188 1171 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 1341 1342 1329 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
Our data show that Crp-cAMP binding in vitro (Fig. 5B, E) is correlated with reduced transcription in vivo (Fig. 6), and that RNAP generates a protection pattern at PgltB in the presence of Crp-cAMP (Fig. 7, lane 7) different from the pattern yielded by RNAP in the presence of IHF + Lrp (Fig. 3B, lane 7). The Crp-cAMP repression thus appears to alter RNAP binding rather than blocking it. The Crp footprint is centered at -65.5 relative to the start of gltB transcription, close to the position from which Crp activates class I promoters [35] where Crp binds between the C-terminal domain of RpoA (alphaCTD) and region 4 of RpoD (sigma70). However optimal spacing from the proximal edge of the Crp binding site to that of the -35 hexamer is 13-16 bp in class I promoters, while in PgltB this spacing is 21 bp (Fig. 2A). Crp may thus repress PgltB by mispositioning or trapping RNAP. Repression has been seen due to mispositioning of RNAP via alternative binding sites [36], or trapping at the promoter [37,38]. A recent global analysis suggests that nearly a quarter of sigma70 (RpoD)-dependent promoters have bound RNAP that is "poised" but not transcribing [39]. RNAP poised at PgltB would allow a rapid increase of GltBD levels in the face of falling ammonium concentrations, as the GdhA reaction becomes increasingly inefficient (Fig. 1).
###end p 44
###begin title 45
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF</italic>
Role of ArgR in repressing gltBDF
###end title 45
###begin p 46
###xml 17 18 17 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 383 406 383 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas aeruginosa </italic>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 451 456 451 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 608 609 608 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 635 636 635 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 1012 1018 1012 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBD </italic>
###xml 383 405 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
As shown in Fig. 1, glutamate is a precursor of ornithine, which in turn is converted to arginine. Thus regulation of GltBD in response to arginine is an example of negative feedback regulation. The relatively modest effects are appropriate given the need for glutamate in many other pathways. A similar feedback regulation of glutamate biosynthesis by ArgR was recently observed in Pseudomonas aeruginosa [40]. The mechanism by which ArgR represses PgltB is not clear, but our evidence is consistent with the possibility that ArgR interferes with formation of the final activation complex. As shown in Fig. 8, and illustrated in Fig. 2, ArgR binds far upstream of the promoter, near the Lrp-binding region. However ArgR does not appear to have a major effect on Lrp binding (Fig. 9A). Our working hypothesis is that ArgR allows pre-assembly of the Lrp-IHF-RNAP complex, but blocks a specific contact required for transcriptional activation. This would resemble the suggested role of Crp (see above) in reducing gltBD expression while allowing rapid return to full activation should the appropriate conditions change.
###end p 46
###begin title 47
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBD</italic>
Role of Lrp in regulation of gltBD
###end title 47
###begin p 48
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
Lrp is not simply a signal of amino acid sufficiency. First, gltBDF is one of the operons for which Lrp regulation is relatively insensitive to the coregulator leucine [5,28]. Second, Lrp levels (like those of the coactivator IHF [41]) are sensitive to the alarmone ppGpp [42], which in turn is affected by sufficiency of both amino acids and other nutrients [43]. Lrp levels vary between media, and (like those of the coactivator IHF [41]) also through the growth cycle [42].
###end p 48
###begin p 49
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 210 211 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 282 283 282 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 283 284 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 322 327 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gdhA </italic>
###xml 384 385 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 385 386 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 403 406 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gln</italic>
###xml 412 418 412 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBD </italic>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glnA </italic>
###xml 511 517 511 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBD </italic>
###xml 559 564 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gdhA </italic>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 646 650 646 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glnL</italic>
###xml 656 662 656 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBD </italic>
###xml 727 732 727 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gdhA </italic>
###xml 733 734 733 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 735 736 735 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
Much of what is known about regulation of GdhA, GlnA, and GltBD is consistent with the expected reciprocal pattern between the two pathways shown in Fig. 1. One would expect GdhA levels to parallel those of [NH4+], while GlnA and GltBD levels would perhaps follow the inverse of [NH4+] and parallel those of ATP. In fact, gdhA is repressed by Nac, with repression relieved in high [NH4+], while neither glnA nor gltBD appear to respond substantially to Nac [17,44,45]. Similarly, transcription of both glnA and gltBD is repressed by Crp-cAMP while effects on gdhA are unclear (this work, [34,46]). Conversely, both GlnA activity (indirectly, via glnL) and gltBD transcription are boosted by Lrp, which has no obvious effect on gdhA [5,6,28].
###end p 49
###begin p 50
###xml 19 21 19 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 539 541 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 643 644 639 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 644 645 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 653 659 649 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBD </italic>
###xml 738 743 734 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 751 753 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
Modeling analysis [47] suggests that the major control of relative flux between the alternative pathways shown in Fig. 1 should involve regulation of GlnA activity (via adenylylation and deadenylylation [48]). Lrp has major effects on GlnA expression and adenylylation status in response to ammonia levels [2,5,7]. The effect of Lrp on GlnA expression and activity is indirect, probably involving the direct Lrp effect on GltBD expression that, in turn, modulates the intracellular ratios of alpha-ketoglutarate, glutamate, and glutamine [49]. This model requires changes in gene expression levels for adaptation to sudden large changes in [NH4+], with gltBD needing to be expressed above a threshold level. The 30-40-fold activation of PgltB by Lrp [28] is consistent with a major switch above or below this critical threshold expression level. In contrast, the effects of Crp and ArgR (and of leucine, in this case) are smaller, fine-tuning controls that may modulate the flow of glutamine out of the middle of the GlnA-GltBD pathway.
###end p 50
###begin title 51
Conclusion
###end title 51
###begin p 52
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 88 96 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 924 930 924 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF</italic>
###xml 1253 1261 1253 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 88 95 <span type="species:ncbi:562">E. coli</span>
###xml 1253 1260 <span type="species:ncbi:562">E. coli</span>
Results from this study demonstrate that the physiologically-important gltBDF operon of E. coli is subject to negative as well as positive control, and involves a third member of the group of seven most-global transcriptional regulatory proteins. In addition to the previously-demonstrated direct positive roles of Lrp and IHF, there are direct negative roles for Crp and ArgR. Lrp and IHF appear to stabilize RNAP binding to the promoter, as no RNAP-dependent footprint appears unless both Lrp and IHF are present. Crp-cAMP can replace Lrp + IHF in potentiating footprint formation by RNAP, though the resulting protection patterns are distinct. ArgR alters, but does not prevent, footprint formation by RNAP + Lrp + IHF. It does not appear that either repressor, Crp or ArgR, acts by interfering with binding of the activators or of RNAP. This study does not explore the specific mechanisms of activation or repression at gltBDF, but the results are consistent with the possibility that Crp and ArgR inhibit transcription in such a way as to leave the RNAP poised for rapid transcription initiation when conditions require it. Given the central importance of the regulation of glutamate biosynthesis, reflected by the involvement of Lrp and two other E. coli global regulatory proteins, it would be instructive to know whether this regulatory mechanism is broadly conserved among related bacterial species adapted to different nutritional environments.
###end p 52
###begin title 53
Methods
###end title 53
###begin title 54
Bacterial strains, plasmids and culture conditions
###end title 54
###begin p 55
###xml 77 78 77 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 112 122 112 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli K-</italic>
###xml 155 159 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rph </italic>
###xml 286 288 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 289 291 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 396 397 391 392 <sc xmlns:xlink="http://www.w3.org/1999/xlink">L</sc>
###xml 813 815 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 112 124 <span type="species:ncbi:83333">E. coli K-12</span>
The strains, plasmids and PCR primers used in this study are listed in Table 2. All strains were derivatives of E. coli K-12 W3110 or LP2002 (in which the rph mutation of W3110 was corrected; see below). For beta-galactosidase assays, strains were grown in glucose minimal MOPS medium [50,51] containing ampicillin (20 mug/ml for chromosomal and 80 mug/ml for plasmid-borne resistance) or 7.5 mM L-arginine HCl (Sigma) where indicated. Cultures grown to test the effects of Crp-binding site mutations were grown in MOPS defined-rich medium (Teknova, Hollister, CA) containing 100 mug ampicillin per ml and 1 mM isopropyl-beta-D-thiogalactoside (IPTG), in the presence or absence of 10 muM dibutyryl-cAMP (BioMol Research Labs, Plymouth Meeting, PA). Plates for most genetic work used agar containing "LB" medium [52].
###end p 55
###begin title 56
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rph</italic>
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Construction of the rph+ strain LP2002 and its derivatives
###end title 56
###begin p 57
###xml 16 26 16 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli K-</italic>
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rph </italic>
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pyrE </italic>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rph </italic>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 527 531 527 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rph </italic>
###xml 564 565 564 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 600 608 600 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 849 853 849 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rph </italic>
###xml 1028 1033 1022 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sacB </italic>
###xml 1039 1041 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1272 1276 1265 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rph </italic>
###xml 1299 1303 1292 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rph </italic>
###xml 1359 1362 1352 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rph</italic>
###xml 1362 1364 1355 1357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 16 28 <span type="species:ncbi:83333">E. coli K-12</span>
###xml 600 607 <span type="species:ncbi:562">E. coli</span>
The widely used E. coli K-12 strain W3110 contains a frameshift mutation in rph associated with decreased levels of the pyrE product orotate phosphoribosyltransferase [29]. This frameshift was corrected as follows. A 790 bp fragment of rph and downstream sequence was amplified from W3110 chromosomal DNA using the polymerase chain reaction (PCR) and the overlap extension procedure [53]. The primers used were rph1-4 (Table 2). Primers rph2 and rph3 contain the additional base pair required to correct the frame shift in the rph gene (underlined italic in Table 2). The PCR product was cloned into E. coli strain XL-1Blue (Stratagene) using the pGEMT-easy vector (Promega). The insert was then excised with NotI and ligated into NotI-digested suicide vector pKO3 [54]. Electrocompetent W3110 cells were transformed with pKO3 carrying the modified rph gene, and integrants were selected at 43degreesC. Cells that had lost the plasmid were isolated by plating on LB agar containing 5% sucrose, which selects against the plasmid sacB gene [54]. Colonies from LB-sucrose plates were replica plated onto unsupplemented LB and LB-chloramphenicol (20 mug/ml). Colonies that grew on LB plates but not on LB-chloramphenicol were screened for correction of the frame shift in the rph gene by amplifying the rph region by PCR and sequencing the product. The resulting rph+ strain was designated LP2002.
###end p 57
###begin p 58
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac </italic>
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 201 205 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacI</italic>
###xml 406 411 406 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cynX </italic>
###xml 434 441 434 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZYA </italic>
###xml 547 554 547 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZYA </italic>
###xml 596 601 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacA </italic>
###xml 637 642 637 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacA </italic>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 753 760 749 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZYA </italic>
###xml 886 890 882 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac </italic>
###xml 974 984 970 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB-lacZ </italic>
###xml 1020 1022 1016 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1023 1025 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1075 1077 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
The lac operon was deleted from strain LP2002 using the overlap extension protocol [53] with primers lac6-9 (Table 2). The lac6 primer corresponds to nucleotides 814 to 842 within the coding region of lacI; the lac7 primer is complementary to the 5' region of primer lac8; the 3' end of lac8 bridges the deletion region (see below), and lac9 corresponds to nucleotides 1019 to 1044 of the coding region of cynX gene downstream of the lacZYA operon. The final amplified product has a deletion starting immediately upstream of the -10 region of the lacZYA operon and extending to the 3' end of the lacA gene, leaving the last 19 codons of lacA intact. This product was introduced into the chromosome of LP2002 using the suicide vector pKO3 [54]. The DeltalacZYA recombinants were identified as white colonies on LB-Xgal plates, and the deletion was verified by amplifying the chromosomal lac region and sequencing the fragment. The resultant strain was designated LP2010. The gltB-lacZ transcriptional fusion from LP1000 [14,55] was introduced into LP2010 via P1 transduction [55] and designated LP2020.
###end p 58
###begin title 59
###xml 21 26 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">argR </italic>
Construction of DeltaargR strains
###end title 59
###begin p 60
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">argR </italic>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">argR </italic>
###xml 118 121 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac</italic>
###xml 230 231 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 309 314 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">argR </italic>
###xml 380 385 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">argR </italic>
###xml 479 484 475 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">argR </italic>
###xml 572 574 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 675 680 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">argR </italic>
###xml 780 785 772 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">argR </italic>
A portion of argR was deleted from strains LP1000 and LP2020 as follows. The argR gene from strain PS2209 (W3110 Deltalac-169 from F. C. Neidhardt) was amplified from chromosomal DNA by PCR, using the primers arg1 and arg2 (Table 2). The amplified product was ligated into the pGEMTeasy vector (Promega). The argR fragment was excised from the vector with NotI, and the region of argR coding for amino acids 15-90 were deleted in-frame by removing a DraI/EcoRV fragment from the argR gene and religating the blunt ends. This fragment was ligated into suicide vector pKO3 [54] and introduced into strains LP1000 and LP2020. Prospective mutants were screened by amplifying the argR region from their genomic DNA; the amplified fragment was shorter in the deletion mutants. The DeltaargR strains were designated LP1050 (LP1000 derivative) and LP2023 (LP2020 derivative).
###end p 60
###begin title 61
CipherGen ProteinChiptrade mark assays
###end title 61
###begin p 62
###xml 625 633 625 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 625 632 <span type="species:ncbi:562">E. coli</span>
Surface-enhanced laser desorption and ionization (SELDI) ProteinChip technology (Ciphergen Biosystems, currently distributed by BioRad, Hercules, CA) was used to identify proteins binding to the upstream region of the gltBDF operon. In this approach, biotin-labeled gltB DNA (from -406 to +246) was attached to streptavidin-coated chips and incubated with centrifugally-cleared whole-cell extracts. The masses of proteins that bound to the DNA fragments were determined using SELDI mass spectroscopy. This binding experiment was carried out under nonstringent conditions so as to detect relatively weak binding interactions. E. coli cells (strain W3110) were grown in glucose minimal MOPS medium and opened using glass beads in a BeadBeater (BioSpec Products, Bartlesville, OK). PS-1 (carbonyl diimidazole) ProteinChips were coated with streptavidin (Pierce, Immunopuretrade mark) at 0.2 microgram/spot, washed, and the unbound sites were blocked with 1 M ethanolamine (pH 8.0). The DNA, generated by PCR using biotinylated primers, was first bound to the streptavidin on the chip, and then incubated with cell extract in 20 mM Tris-acetate (pH 8.0), 0.1 mM EDTA, 0.1 mM dithiothreitol, 250 mM NaCl, 4 mM Mg acetate, 12.5% glycerol (v:v), and 200 mug/ml of salmon sperm DNA (Amersham Pharmacia Biotech, N.J.). The chips were washed with 20 mM Tris-acetate containing 0.1% Triton X-100. The matrix EAM-1 (Ciphergen) was added to the chip prior to SELDI mass analysis.
###end p 62
###begin title 63
Expression and purification of Lrp, ArgR, Crp and IHF
###end title 63
###begin p 64
###xml 242 244 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 257 261 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">argR</italic>
###xml 263 266 262 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp</italic>
###xml 268 273 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">himA </italic>
###xml 277 282 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">himD </italic>
###xml 377 382 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">argR </italic>
###xml 436 437 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 498 501 497 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nde</italic>
###xml 503 506 502 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 724 729 723 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 732 734 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
In all cases, protein purity was assessed from single (or, in the case of IHF, double) Coomassie-stained bands when mug amounts were loaded onto SDS polyacrylamide gels. Lrp was purified from strain JWD3 and isolated as previously described [28]. The genes argR, crp, himA and himD (the latter two coding for IHF subunits) were amplified from strain W3110 chromosomal DNA. The argR gene was amplified using primers arg3 and arg4 (Table 2), cloned into the expression vector pET23b (Novagen) at the NdeI/XhoI sites creating pLP1060, and introduced into the expression host BL21(DE3) (Novagen) which carries an inducible gene for T7 RNAP. The protein was purified from the resulting strain LP1060, as described by Sunnerhagen et al. [56].
###end p 64
###begin p 65
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crp </italic>
###xml 62 63 62 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nde</italic>
###xml 88 91 88 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
The crp gene was amplified using primers crp5 and crp6 (Table 2), ligated into the NdeI/XhoI sites of expression vector pET29a (Novagen) to create pLP1070, and introduced into strain BL21(DE3) resulting in strain LP1070. The overexpressed protein was purified using a nickel affinity column (Pharmacia) since the wild type Crp (without a his-tag) binds nickel columns with moderate affinity [57].
###end p 65
###begin p 66
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">himA </italic>
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">himD </italic>
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 232 235 232 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 237 240 237 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
The genes himA and himD were amplified from W3110 chromosomal DNA using primers himA1 and himA2 and primers himD1 and himD2 (Table 2). The amplified products were ligated in tandem into the expression vector pET28a (Novagen) at the NcoI/BamHI sites to create pLP1080, and introduced into strain BL21(DE3). The strain was designated LP1080. IHF with an N-terminal histidine tag on HimA was purified using a 3 ml Hi-Trap Heparin Sepharose column from Pharmacia [58].
###end p 66
###begin title 67
###xml 17 27 17 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB-lacZ </italic>
Construction of PgltB-lacZ fusion and variant with altered Crp-binding site
###end title 67
###begin p 68
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 56 64 56 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 427 428 427 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glt </italic>
###xml 586 591 582 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
###xml 56 63 <span type="species:ncbi:562">E. coli</span>
The promoter region upstream of gltB was amplified from E. coli chromosomal DNA using primers gltP1-2 (Table 2), and the resulting PCR product was digested with BamHI and SalI. This product was ligated into pBH403, a derivative of pKK232-8 with a promoterless lacZ gene between two bidirectional transcription terminators, to generate pPM2005 (Table 2). This process was repeated with a mutagenic primer pair (gltcrp1-2, Table 2) to generate pPM2006, which has alterations within the Crp-binding site in the glt promoter. Plasmids were sequence confirmed and used to transform the DeltalacZ W3110 derivative PS2209.
###end p 68
###begin title 69
beta-galactosidase assays
###end title 69
###begin p 70
###xml 182 183 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">o</italic>
###xml 256 261 250 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 264 266 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
Cultures were grown to exponential phase in the indicated media. Samples were taken at 30-min intervals throughout the growth period. Levels of beta-galactosidase were determined by o-nitrophenyl-beta-D-galactoside (ONPG) hydrolysis as described by Platko et al. [59]. beta-galactosidase levels were plotted against culture absorbance, and points were fitted via linear regression. The resulting slope yields the beta-galactosidase acitivity.
###end p 70
###begin title 71
Mobility shift and DNase I protection assays
###end title 71
###begin p 72
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 816 817 814 815 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 828 829 826 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 861 867 <span type="species:ncbi:9913">bovine</span>
RNA polymerase holoenzyme was purchased from Epicentre Biotechnologies (Madison, WI). Assays were carried out as described in Paul et al. [14] except where indicated. In electrophoretic mobility shift experiments involving ArgR, the reaction mixture and the polyacrylamide gel both contained 5 mM L-arginine, and the running buffer (1 x TBE [90 mM Tris borate, pH 8.3, 0.2 mM EDTA]) contained 1 mM L-arginine. Crp-DNA binding was carried out in a buffer modified from Seoh and Tai [60] containing 10 mM Tris-HCl (pH 8.0), 50 mM KCl, 1.0 mM EDTA, 0.1 mM DTT, 50 mug/ml BSA, 10 mug/ml poly (dI-dC):poly(dI-dC) from Pharmacia and 12.5% glycerol. cAMP (20 mM, Sigma) was added to the reaction buffer, the gel and the running buffer (0.5 x TBE). The buffer for DNase I protection assays (10 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 1 mM CaCl2, 2 mM dithiothreitol, 50 mg of bovine serum albumin/ml and 2 mug of poly(dI-dC):poly(dI-dC)/ml) contained 5 mM L-arginine or 20 mM cAMP for reactions involving ArgR and Crp respectively.
###end p 72
###begin title 73
Authors' contributions
###end title 73
###begin p 74
LP carried out most of the laboratory experiments, with PM responsible for those involving alteration of the Crp binding sites and tests of their function. LP, RB and RM planned the experiments and analyzed the data. All authors contributed to the writing of the manuscript, with RB having primary responsibility for the writing and the figures. All authors read and approved the final manuscript.
###end p 74
###begin title 75
Acknowledgements
###end title 75
###begin p 76
The authors thank George M. Church of Harvard University, Cambridge, MA, for the plasmid pKO3, Ruth Van Bogelen of Pfizer Inc., Ann Arbor, MI, for help with the SELDI analysis, and the anonymous reviewers for helpful comments. This project was supported in part by a grant from the U.S. National Science Foundation to RGM and RMB (MCB-9807237), and by a grant to RMB from the U.S. National Institutes of Health (AI054716).
###end p 76
###begin article-title 77
Identifying global regulators in transcriptional regulatory networks in bacteria
###end article-title 77
###begin article-title 78
###xml 47 63 <span type="species:ncbi:562">Escherichia coli</span>
Nitrogen assimilation and global regulation in Escherichia coli
###end article-title 78
###begin article-title 79
###xml 41 57 <span type="species:ncbi:562">Escherichia coli</span>
Pathway choice in glutamate synthesis in Escherichia coli
###end article-title 79
###begin article-title 80
###xml 9 25 <span type="species:ncbi:562">Escherichia coli</span>
Why does Escherichia coli have two primary pathways for synthesis of glutamate?
###end article-title 80
###begin article-title 81
Characterization of the regulon controlled by the leucine responsive regulatory protein
###end article-title 81
###begin article-title 82
Adapation to famine: a family of stationary-phase genes revealed by microarray analysis
###end article-title 82
###begin article-title 83
###xml 79 95 <span type="species:ncbi:562">Escherichia coli</span>
The leucine-responsive regulatory protein, a global regulator of metabolism in Escherichia coli
###end article-title 83
###begin article-title 84
###xml 67 88 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Prolonged stationary-phase incubation selects for lrp mutations in Escherichia coli K-12
###end article-title 84
###begin article-title 85
###xml 28 44 <span type="species:ncbi:562">Escherichia coli</span>
Sigma factor selectivity of Escherichia coli RNA polymerase: role for CRP, IHF and Lrp transcription factors
###end article-title 85
###begin article-title 86
###xml 63 79 <span type="species:ncbi:562">Escherichia coli</span>
Growth phase-dependent variation in protein composition of the Escherichia coli nucleoid
###end article-title 86
###begin article-title 87
###xml 39 55 <span type="species:ncbi:562">Escherichia coli</span>
Interplay between global regulators of Escherichia coli: effect of RpoS, Lrp and H-NS on transcription of the gene osmC
###end article-title 87
###begin article-title 88
###xml 119 135 <span type="species:ncbi:562">Escherichia coli</span>
The leucine-responsive regulatory protein (Lrp) acts as a specific repressor for sigmaS-dependent transcription of the Escherichia coli aidB gene
###end article-title 88
###begin article-title 89
Hns, RpoS and Lrp mutations affect stationary-phase survival at high osmolarity
###end article-title 89
###begin article-title 90
Activation from a distance: Roles of Lrp and integration host factor in transcriptional activation of gltBDF
###end article-title 90
###begin article-title 91
###xml 87 103 <span type="species:ncbi:562">Escherichia coli</span>
Adenosine 3':5'-cyclic monophosphate control of the enzymes of glutamine metabolism in Escherichia coli
###end article-title 91
###begin article-title 92
###xml 118 138 <span type="species:ncbi:83333">Escherichia coli K12</span>
A reassessment of the FNR regulon and transcriptomic analysis of the effects of nitrate, nitrite, NarXL, and NarQP as Escherichia coli K12 adapts from aerobic to anaerobic growth
###end article-title 92
###begin article-title 93
###xml 50 66 <span type="species:ncbi:562">Escherichia coli</span>
Nitrogen regulatory protein C-controlled genes of Escherichia coli: scavenging as a defense against nitrogen limitation
###end article-title 93
###begin article-title 94
###xml 79 95 <span type="species:ncbi:562">Escherichia coli</span>
GadE (YhiE): a novel activator involved in the response to acid environment in Escherichia coli
###end article-title 94
###begin article-title 95
###xml 46 62 <span type="species:ncbi:562">Escherichia coli</span>
EcoCyc: a comprehensive database resource for Escherichia coli
###end article-title 95
###begin article-title 96
###xml 32 48 <span type="species:ncbi:562">Escherichia coli</span>
Cyclic AMP and cell division in Escherichia coli
###end article-title 96
###begin article-title 97
Global regulation of gene expression
###end article-title 97
###begin article-title 98
###xml 71 87 <span type="species:ncbi:562">Escherichia coli</span>
Catabolite repression by glucose 6-phosphate, gluconate and lactose in Escherichia coli
###end article-title 98
###begin article-title 99
###xml 80 96 <span type="species:ncbi:562">Escherichia coli</span>
Determinants of DNA bending in the DNA-cyclic AMP receptor protein complexes in Escherichia coli
###end article-title 99
###begin article-title 100
###xml 24 44 <span type="species:ncbi:83333">Escherichia coli K12</span>
The arginine regulon of Escherichia coli K12: A study of repressor-operator interactions and of in vitro binding affinities versus in vivo repression
###end article-title 100
###begin article-title 101
###xml 37 57 <span type="species:ncbi:83333">Escherichia coli K12</span>
Binding of the arginine repressor of Escherichia coli K12 to its operator sites
###end article-title 101
###begin article-title 102
###xml 126 142 <span type="species:ncbi:562">Escherichia coli</span>
A nucleoprotein activation complex between the leucine-responsive regulatory protein and DNA upstream of the gltBDF operon in Escherichia coli
###end article-title 102
###begin article-title 103
The Hill equation revisited: uses and misuses
###end article-title 103
###begin article-title 104
###xml 31 47 <span type="species:ncbi:562">Escherichia coli</span>
Regulation of gltBDF operon of Escherichia coli: How a leucine-insensitive operon is regulated by leucine-responsive regulatory protein
###end article-title 104
###begin article-title 105
The Esherichica coli K-12 "wild types" W3110 and MG1655 have an rph frameshift mutation that leads to pyrimidine starvation due to low pyrE expression levels
###end article-title 105
###begin article-title 106
IHF and HU: flexible architects of bent DNA
###end article-title 106
###begin article-title 107
###xml 100 116 <span type="species:ncbi:562">Escherichia coli</span>
Effects of integration host factor and DNA supercoiling on transcription from the ilvPG promoter of Escherichia coli
###end article-title 107
###begin article-title 108
###xml 72 84 <span type="species:ncbi:10710">phage lambda</span>
Participation of IHF and a distant UP element in the stimulation of the phage lambda PL promoter
###end article-title 108
###begin article-title 109
###xml 81 97 <span type="species:ncbi:562">Escherichia coli</span>
Transcriptome analysis of Crp-dependent catabolite control of gene expression in Escherichia coli
###end article-title 109
###begin article-title 110
###xml 154 170 <span type="species:ncbi:562">Escherichia coli</span>
The CRP-cAMP complex and downregulation of the glnAp2 promoter provides a novel regulatory linkage between carbon metabolism and nitrogen assimilation in Escherichia coli
###end article-title 110
###begin article-title 111
###xml 45 61 <span type="species:ncbi:562">Escherichia coli</span>
Determinants of the C-terminal domain of the Escherichia coli RNA polymerase alpha subunit important for transcription at class I cyclic AMP receptor protein-dependent promoters
###end article-title 111
###begin article-title 112
###xml 54 70 <span type="species:ncbi:562">Escherichia coli</span>
An inactive open complex mediated by an UP element at Escherichia coli promoters
###end article-title 112
###begin article-title 113
The bacterial DNA-binding protein H-NS represses ribosomal RNA transcription by trapping RNA polymerase in the initiation complex
###end article-title 113
###begin article-title 114
lacP1 promoter with an extended -10 motif. Pleiotropic effects of cyclic AMP protein at different steps of transcription initiation
###end article-title 114
###begin article-title 115
###xml 68 75 <span type="species:ncbi:562">E. coli</span>
The transition between transcriptional initiation and elongation in E. coli is highly variable and often rate limiting.
###end article-title 115
###begin article-title 116
###xml 147 169 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
The arginine regulatory protein mediates repression by arginine of the operons encoding glutamate synthase and anabolic glutamate dehydrogenase in Pseudomonas aeruginosa
###end article-title 116
###begin article-title 117
###xml 39 55 <span type="species:ncbi:562">Escherichia coli</span>
Expression of the genes coding for the Escherichia coli integration host factor are controlled by growth phase, rpoS, ppGpp and by autoregulation
###end article-title 117
###begin article-title 118
###xml 54 70 <span type="species:ncbi:562">Escherichia coli</span>
Effects of nutrition and growth rate on Lrp levels in Escherichia coli
###end article-title 118
###begin article-title 119
###xml 29 45 <span type="species:ncbi:562">Escherichia coli</span>
ppGpp: a global regulator in Escherichia coli
###end article-title 119
###begin article-title 120
###xml 38 54 <span type="species:ncbi:562">Escherichia coli</span>
Transcriptional repression of gdhA in Escherichia coli is mediated by the Nac protein
###end article-title 120
###begin article-title 121
###xml 50 66 <span type="species:ncbi:562">Escherichia coli</span>
The nac (nitrogen assimilation control) gene from Escherichia coli
###end article-title 121
###begin article-title 122
Identification of the CRP regulon using in vitro and in vivo transcriptional profiling
###end article-title 122
###begin article-title 123
###xml 67 83 <span type="species:ncbi:562">Escherichia coli</span>
The multifarious short-term regulation of ammonium assimilation of Escherichia coli: dissection using an in silico replica
###end article-title 123
###begin article-title 124
The two opposing activities of adenylyl transferase reside in distinct homologous domains, with intramolecular signal transduction
###end article-title 124
###begin article-title 125
###xml 18 34 <span type="species:ncbi:562">Escherichia coli</span>
The regulation of Escherichia coli glutamine synthetase revisited: role of 2-ketoglutarate in the regulation of glutamine synthetase adenylylation state
###end article-title 125
###begin article-title 126
Culture medium for enterobacteria
###end article-title 126
###begin article-title 127
Lysogeny at mid-twentieth century: P1, P2, and other experimental systems
###end article-title 127
###begin article-title 128
Simultaneous introduction of multiple mutations using overlap extension PCR
###end article-title 128
###begin article-title 129
###xml 83 99 <span type="species:ncbi:562">Escherichia coli</span>
Methods for generating precise deletions and insertions in the genome of wild-type Escherichia coli: Application to open reading frame characterization
###end article-title 129
###begin article-title 130
Solution structure of the DNA-binding domain and model for the complex of mutlifunctional hexameric arginine repressor with DNA
###end article-title 130
###begin article-title 131
Ni+-Affinity purification of untagged cAMP receptor protein
###end article-title 131
###begin article-title 132
###xml 16 32 <span type="species:ncbi:562">Escherichia coli</span>
Purification of Escherichia coli integration host factor (IHF) in one chromatographic step
###end article-title 132
###begin article-title 133
###xml 20 36 <span type="species:ncbi:562">Escherichia coli</span>
The ilvIH operon of Escherichia coli is positively regulated
###end article-title 133
###begin article-title 134
Catabolic repression of secB expression is positively controlled by cyclic AMP (cAMP) receptor protein-cAMP complexes at the transcriptional level
###end article-title 134
###begin article-title 135
Plasmid vectors for the selection of promoters
###end article-title 135
###begin article-title 136
Nature of the promoter activated by C.PvuII, an unusual regulatory protein conserved among restriction-modification systems
###end article-title 136
###begin article-title 137

###end article-title 137
###begin article-title 138
Conservation of the binding site for the arginine repressor in all bacterial lineages
###end article-title 138
###begin title 139
Figures and Tables
###end title 139
###begin p 140
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Biosynthesis and metabolic uses of L-glutamic acid</bold>
###xml 337 341 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
Biosynthesis and metabolic uses of L-glutamic acid. The two alternative pathways from alpha-ketoglutarate (alphaKG) to glutamate (Glu) are shown by the thick arrows, as described by equations 1-4 in the Introduction. The gray arrow (left) represents equation 1, while the black arrow (right) represents the net sum of equations 2 and 3 (i.e., equation 4). Glu is one of the small minority of amino acids for which the great bulk of the molecules are used for purposes other than direct incorporation into proteins [2]. A number of transaminases use the alpha-amino group of Glu. Other uses of Glu were identified from the BioCyc website [63].
###end p 140
###begin p 141
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 0 22 0 22 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>gltBDF </italic>promoter region</bold>
###xml 24 27 24 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB</italic>
###xml 528 535 528 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 708 709 708 709 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 723 730 723 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 809 816 809 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 1099 1103 1099 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glt </italic>
gltBDF promoter region. A. Sequence of region upstream of gltB. Nucleotides shown as shaded capitals represent promoter elements or binding sites for the indicated regulatory proteins, as identified in this work and earlier studies (see references in text). The borders shown for binding sites are based on comparison to consensus sequences, and are consistent with DNAse I footprints reported in this study. The binding site for Fnr is shown as a dashed box because it has not been experimentally confirmed (see information on gltBDF at BioCyc.org). The color-shaded background indicates three broad regions of the promoter (initiation region, blue; Lrp-binding region, green; ArgR-binding region, yellow). B. A model for gltBDF transcriptional regulation. Lrp and IHF bind and, according to the model, bend gltBDF promoter DNA such that an upstream regulatory sequence or Lrp surface required for stable binding of RNAP is brought in contact with RNAP that is loosely associated with the promoter region. This positive interaction (and not Lrp binding) is partially abolished by ArgR-Arg bound to glt DNA. In the presence of Crp-cAMP, RNAP association with the promoter is stabilized but in a nonproductive manner, leading to transcriptional repression. Background shading matches that in part A.
###end p 141
###begin p 142
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DNAse I protection of the <italic>gltBDF </italic>promoter region by Lrp, IHF, and RNA polymerase</bold>
###xml 82 83 82 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 113 120 113 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 392 393 392 393 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 409 414 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 488 490 488 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
DNAse I protection of the gltBDF promoter region by Lrp, IHF, and RNA polymerase. A. DNase I protection assay of gltBDF promoter region in the presence of both Lrp and IHF. A fragment of gltB DNA from -325 to +8 was used in the reaction. The first 4 lanes represent a sequencing ladder of the region. In all cases where it was added, Lrp was used at 2 nM. The amounts of IHF are shown in nM. B. A fragment of gltB DNA from -571 to +51, labeled at the +51 end of the template strand using 32P, was used. When present, the concentration of RNAP was 30 nM, Lrp 100 nM and IHF 100 nM. The first 4 lanes represent a sequencing ladder of the template strand of the region.
###end p 142
###begin p 143
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 48 56 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Masses of polypeptides associated with <italic>gltB </italic>DNA <italic>in vitro</italic></bold>
###xml 183 191 183 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 183 190 <span type="species:ncbi:562">E. coli</span>
Masses of polypeptides associated with gltB DNA in vitro. Surface-enhanced laser desorption and ionization (SELDI; Ciphergen Biosystems) was used to identify proteins from whole-cell E. coli extracts binding to biotin-labeled gltB DNA (from -406 to +246). The DNA was attached to streptavidin-coated chips, incubated with the extracts, and washed prior to mass analysis. Parts A and B show different mass ranges. The vertical arrows indicate the theoretical positions of the indicated polypeptides; in each case the mass shown assumes removal of the N-terminal methionine.
###end p 143
###begin p 144
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Interactions between Crp and the <italic>gltBDF </italic>promoter region</bold>
###xml 57 58 57 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glt </italic>
###xml 366 367 366 367 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 415 419 415 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glt </italic>
###xml 494 495 493 494 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 710 714 709 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cat </italic>
###xml 720 722 719 721 <bold xmlns:xlink="http://www.w3.org/1999/xlink"> D</bold>
###xml 796 803 795 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 822 827 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 870 871 869 870 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 895 899 894 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glt </italic>
###xml 921 926 920 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB </italic>
###xml 710 713 <span type="species:ncbi:9685">cat</span>
Interactions between Crp and the gltBDF promoter region. A. The glt Crp-binding sequence (top) compared to the consensus Crp binding sequence (middle). The most-conserved elements of the Crp sequence are shaded, and matches to the consensus are underlined. The bottom sequence shows the mutations (lowercase) that were introduced for the experiment shown in Fig. 6. B. Gel mobility shift analysis of Crp binding to glt DNA region -406 to +246. The running buffer and gel contained 20 muM cAMP. C. Gel mobility shift analysis as in (B), except that two DNAs are used. One is WT, and the other has the region from -128 to -48 replaced by an equal length of exogenous DNA (amplified from the coding region of the cat gene). D. Gel mobility shift assay showing simultaneous binding of Crp and IHF to gltBDF DNA. A fragment of gltB DNA from -203 to +8 was used in the assay. E. DNAse I protection of glt DNA by Crp binding. A gltB DNA fragment from -203 to +161 labeled at the -203 end of the partner strand was used for the assay. The first 4 lanes represent the sequencing ladder of the partner strand. Crp concentrations of 0, 12.5, 25, 50, 100 and 200 nM were used in the assay.
###end p 144
###begin p 145
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 0 101 0 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of dibutyryl-cAMP on expression from P<italic>gltBDF </italic>and a mutant form with altered Crp binding sites</bold>
###xml 255 256 254 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 258 259 257 258 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 286 290 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac </italic>
###xml 313 314 312 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 333 345 332 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF-lacZ </italic>
###xml 369 370 368 369 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 398 403 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
###xml 429 436 428 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
Effects of dibutyryl-cAMP on expression from PgltBDF and a mutant form with altered Crp binding sites. Cells were grown in a MOPS-based defined glucose rich medium with (closed symbols) or without (open symbols) 10 muM dibutyryl-cAMP. All strains were Crp+. A. Expression of the native lac operon (strain W3110). B. Expression of a PgltBDF-lacZ fusion (strain PM2003). C. Expression of a fusion of lacZ to the mutant version of PgltBDF shown in the bottom line of Fig. 5A (strain PM2004).
###end p 145
###begin p 146
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of Crp on protection of the <italic>gltBDF </italic>promoter by RNAP</bold>
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
Effect of Crp on protection of the gltBDF promoter by RNAP. A fragment of gltBDF DNA from -571 to +51, labelled at the +51 end was used for DNase I protection assays. The first 4 lanes represent a sequencing ladder of the region. RNAP was used at 30 nM and Crp at 100 nM. Reactions with CRP contained 2mM cAMP.
###end p 146
###begin p 147
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Interactions between ArgR and the <italic>gltBDF </italic>promoter region</bold>
###xml 58 59 58 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 260 261 260 261 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 337 341 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glt </italic>
###xml 429 430 429 430 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 499 505 499 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF</italic>
Interactions between ArgR and the gltBDF promoter region. A. The ArgR-binding sequences upstream of gltBDF (top two lines) compared to the symmetrical consensus ArgR-binding site [64]. Matches to the consensus are underlined. W = A or T, and N = A, C, G or T. B. Gel mobility shift analysis of ArgR binding to the region -406 to +246 of glt DNA. L-arginine was present in the reactions, the gel and running buffer (see Methods). C. DNase I protection assay of the region -462 to +161 bp upstream of gltBDF, labelled at the -462 end of the partner strand. The first 4 lanes represent a sequencing ladder of the partner strand in this region. ArgR concentrations of 0, 3.13, 6.25, 12.5, and 25 nM were used, and 5 mM L-arginine was present.
###end p 147
###begin p 148
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of ArgR on protection of the <italic>gltBDF </italic>promoter by RNAP and Lrp</bold>
###xml 134 135 134 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 139 146 139 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
###xml 263 264 263 264 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 280 287 280 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
Effect of ArgR on protection of the gltBDF promoter by RNAP and Lrp. The first 4 lanes represent the sequencing ladder of the region. A. A gltBDF DNA fragment from -462 to +161 labeled at the -462 end was used. The concentrations of both Lrp and ArgR were 25 nM. B. A fragment of gltBDF DNA from -571 to +51, labeled at the +51 end was used. The concentrations of proteins used were as follows: ArgR 25 nM, RNAP 50 nM, Lrp 25 nM and IHF 50 nM. Reactions contained 5 mM L-arginine.
###end p 148
###begin p 149
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltB</italic>
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
Effects of arginine and ArgR on gltB::lacZ expression
###end p 149
###begin p 150
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1 </sup>
1 One unit of LacZ (beta-galactosidase) activity is defined as 1 nmol of ONPG hydrolyzed per min.
###end p 150
###begin p 151
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 95 97 95 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
2 Samples were taken at several culture densities, and the resulting LacZ activity was plotted vs. culture density (as in Fig. 6). The activity was calculated from the slope of the line; in every case, the correlation coefficient of the least squares regression was >/= 0.99.
###end p 151
###begin p 152
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
3 Arginine hydrochloride was added to the medium to a final concentration of 7.5 mM.
###end p 152
###begin p 153
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
4 These results were obtained on a different day from the other experiments.
###end p 153
###begin p 154
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 0 7 <span type="species:ncbi:562">E. coli</span>
E. coli strains1, plasmids, and primers used in this work
###end p 154
###begin p 155
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 17 35 17 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli K</italic>
###xml 17 38 <span type="species:ncbi:83333">Escherichia coli K-12</span>
1All strains are Escherichia coli K-12.
###end p 155
###begin p 156
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gltBDF </italic>
2The underlined bases alter the Crp-binding site in the gltBDF promoter.
###end p 156
###begin p 157
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rph </italic>
3The underlined italic base is inserted to replace the base deleted in the rph mutation.
###end p 157

